{"id":"NCT02674529","sponsor":"Marta Peciña, MD PhD","briefTitle":"Study of Neural Responses Induced by Antidepressant Effects","officialTitle":"Study of Neural Responses Induced by Simulated Antidepressants","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-09","primaryCompletion":"2021-05","completion":"2021-05","firstPosted":"2016-02-04","resultsPosted":"2022-11-03","lastUpdate":"2022-11-03"},"enrollment":60,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Escitalopram","otherNames":["Lexapro"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"BEHAVIORAL","name":"Real-time Neurofeedback fMRI task pre- and post-RCT","otherNames":[]}],"arms":[{"label":"Antidepressant Treatment","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The proposed work aims to examine the neural changes associated with fast-acting antidepressant treatments in order to develop imaging-based biomarkers of treatment response for depression.","primaryOutcome":{"measure":"Change in Montgomery-Åsberg Depression Rating Scale (MADRS) Scores","timeFrame":"baseline and week 8","effectByArm":[{"arm":"Changes in MADRS Scores From Baseline to Week 8 Within the Antidepressant Treatment Arm","deltaMin":11,"sd":9},{"arm":"Changes in MADRS Scores From Baseline to Week 8 Within the Placebo Arm","deltaMin":12,"sd":9}],"pValues":[{"comp":"OG000 vs OG001","p":"0.58"},{"comp":"OG000 vs OG001","p":"0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":["Fatigue","Nausea","Insomnia","Appetite Disturbances","Dizziness"]}}